Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Derma Remedies
WARNING LETTER
•Derma Remedies

Derma Remedies – FDA Warning Letter

Record Details

The FDA and FTC issued a Warning Letter to Derma Remedies, specifically Mr. John Fields, regarding the marketing of H-Stop Dx, H-Guard Dx, Molluscum Dx, and Wart Dx on www.dermaremedies.com.

The FDA determined these products are unapproved new drugs and misbranded. Violations include: - **Unapproved New Drugs:** Products are marketed for conditions like herpes, molluscum contagiosum, and warts, which are not covered by any OTC monograph or ongoing rulemaking. They are considered "new drugs" lacking FDA-approved New Drug Applications (NDAs), violating sections 301(d) and 505(a) of the Act. - **Misbranding (Lack of Adequate Directions for Use):** Conditions like genital herpes, molluscum contagiosum, and genital warts are not amenable to self-diagnosis and treatment by laypersons. Therefore, adequate directions for safe use by a layman cannot be provided, violating section 502(f)(1) of the Act. - **Misbranding (Dangerous to Health):** H-Stop Dx and H-Guard Dx are deemed dangerous to health under section 502(j) because claims for herpes prevention, treatment, and cure may cause consumers to forgo or delay appropriate medical treatment. - **Inconsistent with OTC Drug Review:** The active ingredients in H-Stop Dx, H-Guard Dx, and Wart Dx

Company
Derma Remedies
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Evelyn Bonnin (District Director)
  • Deborah M. Autor (Former FDA Deputy Commissioner)
  • Mary K. Engle (Associate Director)
View Company Profile

ID · 14d6b5d5-8ac7-4a42-bf05-be8d4c37fedd

Violation Codes10
21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 35221 U.S.C. 352(f)(1)21 U.S.C. 352(j)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 321(p)21 CFR 201.521 CFR 201.100(c)(2)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Derma Remedies
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.